NoticeThis is an independent non-profit initiative. We are not affiliated with the European Medicines Agency (EMA) or the official CTIS system. For the official EU Clinical Trials Information System, visit:
EMA Registry →
Mature B-Cell Neoplasm,
Non-Hodgkin Lymphoma,
Diffuse large B-cell lymphoma (DLBCL),
Waldenstrom Macroglobulinemia,
MALT Lymphoma,
Follicular Lymphoma,
Pediatric-Type Follicular Lymphoma,
Large B-cell lymphoma with IRF4 rearrangement,
Epstein-Barr virus (EBCV)–positive diffuse large B-cell lymphoma (DLBCL), Nos,
Burkitt's Lymphoma,
Plasmablastic Lymphoma,
High-grade B-cell Lymphoma,
Primary Cutaneous Follicle Center Lymphoma,
Primary Effusion Lymphoma,
Mantle Cell Lymphoma,
Diffuse large B-cell lymphoma (DLBCL) Germinal Center B-Cell Type,
Primary Mediastinal Large B Cell Lymphoma,
T-Cell/Histiocyte-Rich Lymphoma,
ALK-Positive Large B-Cell Lymphoma,
Primary Cutaneous Diffuse Large B-Cell Lymphoma (DLBCL),
Splenic Marginal Zone Lymphoma,
Chronic Lymphocytic Leukemia,
Nodal Marginal Zone Lymphoma,
HHV8-Positive Diffuse large B-cell lymphoma (DLBCL), Nos
Lymphoplasmacytic Lymphoma,
Duodenal-Type Follicular Lymphoma
1 total trials1 recruiting
Filter these 1 trials by phase, country, sponsor and more.